Mechanisms whereby altered TCF7L2 production and/or function may contribute to the development of type 2 diabetes are not fully understood but likely include a decrease in β-cell mass, impaired insulin processing or release, and impaired incretin signaling in β-cells [34, 35]. The gene discussed is TCF7L2; the disease is type 2 diabetes mellitus.